Nearly 85% of the 1.7 million adolescents with HIV live in sub-Saharan Africa, along with half of the nearly 40 million ...

Discover why starting HIV treatment promptly preserves immune function, prevents transmission, improves quality of life and ...

With only 70 months left to meet the SDGs, the world faces a stark reality in the fight against AIDS, requiring urgent action ...

Roorkee researchers have identified a new potential treatment for Chinkungunya, indicate that Efavirenz, a widely used HIV ...

Five years ago, in the heart of Kibra, Nairobi, Boniface Mukuha, 28, met Medrine Kemunto, 28, in a cybercafé—an unassuming setting for what would become an extraordinary love story. She had just ...

IIT Roorkee researchers have discovered that Efavirenz, an HIV drug, may help treat Chikungunya by reducing virus replication in lab tests and mice models. While promising, clinical trials are needed ...

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.

But turning this crisis into an opportunity is possible. To mitigate the effects of the funding freeze, Bekker said swift ...

Ministry of Health Flags Off Critical Human Immunodeficiency Virus (HIV) Commodities at Mission for Essential Drugs and Supplies (MEDS) ...